Most Read Articles
4 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 4 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 2 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

Clindamycin shows promise as alternative treatment to antibiotics in hidradenitis suppurativa

25 Apr 2019

A recent study has demonstrated the potential of clindamycin as a treatment alternative to antibiotic combination regardless of hidradenitis suppurativa (HS) clinical stage.

This study classified a total of 60 patients with mild-to-moderate-severe HS according to their International Hidradenitis Suppurativa Severity Score System (IHS4) and Hurley scores. Patients were then subdivided into two groups of 30 members each (group A patients received clindamycin plus rifampicin; group B patients were treated with clindamycin alone) and analysed retrospectively.

The authors examined and compared the clinical and ultrasound responses between the groups after 8 weeks of treatment according to the Hidradenitis Suppurativa Clinical Response measure.

Seventeen patients in group A and 19 patients in group B showed clinical responses after the treatment. Improvement in IHS4 score was comparable between the two groups, but group B patients showed better improvement in the Dermatology Life Quality Index and pain Visual Analogue Scale scores.

Furthermore, the two groups had similar reductions in nodule and abscess counts, but patients in group B had greater decrease in the number of draining tunnels.

Age, body mass index, IHS4 score and absence of axillary involvement were significantly associated with Hidradenitis Suppurativa Clinical Response score. Disease-free survival was also comparable between groups A and B.

One limitation of the study was that it was not randomized or placebo-controlled, the authors said.

“Antibiotics are recognized as first-line treatments for HS, but the data on their efficacy are limited,” they noted.

Editor's Recommendations
Most Read Articles
4 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 4 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 2 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.